How This Evidence Evolved
Sepsis Fluid Resuscitation
From protocolized bundles to balanced restraint
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
60 d hospital death: EGDT 21%, standard 18.2%, usual 18.9%
90-day mortality 18.6% vs 18.8%, p=0.90
90-day mortality 29.5% vs 29.2%, p=0.90
Follow-up studies, subgroup analyses, and real-world validation
MAKE30 14.3% vs 15.4%, OR 0.91 (95% CI 0.84–0.99), p=0.04
90-day mortality: balanced solution 26.4% vs saline 27.2% (HR 0.97; 95% CI 0.90–1.05; p=0.47)
Death before home≤90 d: R 14% vs L 14.9%; P=.61
All-cause death at 90 days: balanced solution 21.8% vs saline 22.0% (difference −0.15 percentage points, 95% CI −3.60 to 3.30; P=.90)
Integration into clinical practice guidelines and recommendations
Suggest at least 30 mL/kg IV crystalloid within the first 3 hours of resuscitation in adults with sepsis-induced hypoperfusion (weak recommendation)
Suggest using balanced crystalloids over normal saline for resuscitation (weak recommendation)
Current standard of care and ongoing research directions
Review of passive leg raise, end-expiratory occlusion, pulse-pressure variation, vena-cava variation and fluid-challenge methods
IVC ultrasound for fluid responsiveness: sensitivity 0.63 (95% CI 0.56–0.69), specificity 0.73 (0.67–0.78), pooled AUC 0.79
Landmark Trials in This Story
Early goal-directed therapy in the treatment of severe sepsis and septic shock
In-hospital mortality 30.5% vs 46.5%, p=0.009
A randomized trial of protocol-based care for early septic shock
60 d hospital death: EGDT 21%, standard 18.2%, usual 18.9%
Goal-directed resuscitation for patients with early septic shock
90-day mortality 18.6% vs 18.8%, p=0.90
Trial of early, goal-directed resuscitation for septic shock
90-day mortality 29.5% vs 29.2%, p=0.90
Balanced Crystalloids versus Saline in Critically Ill Adults
MAKE30 14.3% vs 15.4%, OR 0.91 (95% CI 0.84–0.99), p=0.04
Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial.
90-day mortality: balanced solution 26.4% vs saline 27.2% (HR 0.97; 95% CI 0.90–1.05; p=0.47)
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension
Death before home≤90 d: R 14% vs L 14.9%; P=.61
Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults.
All-cause death at 90 days: balanced solution 21.8% vs saline 22.0% (difference −0.15 percentage points, 95% CI −3.60 to 3.30; P=.90)
Prediction of fluid responsiveness. What's new?
Review of passive leg raise, end-expiratory occlusion, pulse-pressure variation, vena-cava variation and fluid-challenge methods
Does Respiratory Variation in Inferior Vena Cava Diameter Predict Fluid Responsiveness: A Systematic Review and Meta-Analysis.
IVC ultrasound for fluid responsiveness: sensitivity 0.63 (95% CI 0.56–0.69), specificity 0.73 (0.67–0.78), pooled AUC 0.79
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.